| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $962K | +41.3% |
| Cost of Revenue | $6.5M | -32.0% |
| Gross Profit | -$5.5M | +37.7% |
| R&D Expense | $10.0M | -49.7% |
| SG&A Expense | $37.3M | +93.2% |
| Operating Income | -$54.5M | -0.2% |
| Pre-tax Income | -$51.4M | +11.8% |
| Income Tax | $0 | — |
| Net Income | -$51.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Accounts Receivable | $1K | — |
| Inventory | $5.5M | +20.8% |
| Current Assets | $5.4M | -45.5% |
| Total Assets | $16.8M | -31.3% |
| Current Liabilities | $21.5M | -10.9% |
| Total Liabilities | $22.4M | -17.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.4M | +56.6% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$1.4M | +81.3% |
| Financing Cash Flow | $17.1M | -59.1% |
| Free Cash Flow | -$15.4M | +57.3% |
| +11.8% |
| EPS (Basic) | -$4.15 | +96.5% |
| EPS (Diluted) | -$4.15 | +96.5% |
| Stockholders' Equity |
| -$5.6M |
| -103.1% |